Lawsuits continue to be filed over Actos, a type 2 diabetes drug developed by Takeda and Eli Lilly. Plaintiffs in the litigation allege that Actos contributed to bladder cancer. Drug makers are accused of failing to disclose this risk to patients and their physicians. Court records indicate that a new Actos lawsuit was filed in June 2016.
The lawsuit, like others consolidated in the Actos multidistrict litigation (MDL) alleges that the plaintiff’s bladder cancer was a result of taking Actos. He alleges that the drug’s side effects ultimately led to economic damage due to medical bills and lost wages, mental and physical pain. The plaintiff took Actos for six years, according to the complaint.
At the time the June lawsuit was filed, the MDL contained over 4,500 lawsuits alleging Actos led to bladder cancer. MDLs are established when there are lawsuits with the same allegations. In order to make legal proceedings move quickly and efficiently, these lawsuits are centralized to one court before one judge. This consolidation helps eliminate duplicate discovery and conserves resources. In the Actos MDL, plaintiffs similarly allege that the manufacturers hid data linking Actos to bladder cancer. Continue reading
A study published in JAMA Oncology stated that androgen deprivation therapy (ADT), a standard treatment for men with prostate cancer, may raise the risk of dementia. The use of ADT has increased dramatically in the last few decades with as many as 500,000 men currently receiving ADT in the United States.
“ADT has a demonstrated survival benefit in some patients with prostate cancer. However, it also has been linked to several adverse health effects”, wrote study authors led by Dr. Kevin T. Nead of Stanford University School of Medicine in California. “A growing body of evidence supports a link between ADT and cognitive dysfunction, including Alzheimer disease.” Continue reading
Thirteen people were killed and 31 others were injured early Sunday morning, October 23, when the USA Holiday tour bus carrying them back from a casino near the Salton Sea crashed into a big rig truck near Palm Springs.
The passengers, many of whom were sleeping, had spent the night at the casino and were on the way back to Los Angeles when the crash occurred about 5:17 a.m., the Los Angeles Times reports. The bus slammed into the back of the truck’s trailer, crushing the front third of the bus. Most of those who died appeared to have been sitting toward the front of the bus. Continue reading
A talcum powder lawsuit is currently on trial in St. Louis, Missouri. The plaintiff in the lawsuit is a 63-year-old California woman who suffers from stage 4 ovarian cancer. She alleges that using talcum powder for feminine hygiene for 44 years has contributed to her cancer, and accuses J&J of failing to warn consumers.
J&J has attempted to have the trial postponed and dismissed. The company suffered significant losses earlier this year, when juries awarded verdicts of $72 million and $55 million to talcum powder plaintiffs. Court document show that J&J tried to postpone the trial, but the judge overseeing the litigation moved the case towards resolution. A week before the trial began, J&J tried to postpone the trial again by trying to move the case to federal court. This motion was also denied. Continue reading
Medtronic has announced that the U.S. Food and Drug Administration (FDA) has classified two global voluntary recalls of HeartWare International’s HeartWare Ventricular Assist Device (HVAD) as Class 1 recalls.
A class 1 recall is the FDA’s most serious recall category, reserved for situations where there is a reasonable risk of serious adverse health consequences or death.
The HVAD helps deliver blood from the heart to the rest of the body. A ventricular assist device is used in patients who are at risk of death from end-stage left ventricular heart failure and who are waiting for a heart transplant. The HVAD system includes a pump that is implanted in the space around the heart (pericardium) and a controller to regulate the speed and function of the pump.
Kraft Heinz is recalling its ready-to-eat “Lunchables Ham and American Cracker Stackers because it is misbranded and contains undeclared allergens, including wheat and soy. These ingredients, which can cause a life-threatening allergic reaction in some individuals, were not listed on the product label. According to an Oct. 9 recall alert posted on the U.S. Department of Agriculture website, the recall affects 959 pounds of packaged lunch products.
The recalled Lunchables were produced on Sept. 21, 2016. The products have a “USE BY” date of 25 DEC 2016 and production times ranging from 9:13 to 10:00 stamped on the side of the container, the alert states. Inside the USDA mark of inspection, consumers can locate the establishment number. Products affected by the recall have establishment number “EST. 537K”. The Lunchables were distributed to Utah and California. Continue reading
A voluntary recall has been issued for Nestlé Drumstick Club 16 count Variety Pack and 24 count Vanilla Pack (with cones marked for easy individual sale). Nestlé USA recalled the product because contact surfaces of equipment tested positive for Listeria monocytogenes. “The products impacted by the voluntary recall were put into distribution inadvertently. No illnesses have been reported to date; the company is initiating this recall as a precautionary action to avoid any potential for consumer illness.” according to an Oct. 7 recall alert posted on the U.S. Food and Drug Administration (FDA) website.
The drumstick ice cream cones themselves did not test positive for Listeria. The recall affects 4.6 fl. oz cones. According to the announcement, the product was manufactured in Bakersfield, California and distributed nationwide. Continue reading
A school bus accident left dozens of New Jersey high school students injured in New City, New York. State police say one school bus rear-ended another while exiting the Palisades Interstate Parkway at Exit 11. Fortunately, there were no major injuries. The school buses were carrying students who attend Northern Valley Regional High School in Demarest, New Jersey.
According to Associated Press, the accident occurred on October 17th just after 2 p.m. All injuries were considered minor, and 40 to 60 students were taken to the hospital for bumps and bruises. Continue reading
In an October 2016 “Urgent Field Safety Notice”, Medtronic warned that some rechargers for its deep brain stimulation devices may be prone to an “error state” and fail to charge. According to the letter, some of its Model 37751 rechargers may become unresponsive and fail to recharge the neurostimulator until they are reset. The company has received reports of the chargers malfunctioning, where they bleep every five seconds while displaying a blank screen.
According to the letter, the “error state” occurs in 2 percent of rechargers manufactured after November 2014 and 0.2 percent of rechargers manufactured before that date. The serial numbers on rechargers manufactured November 2014 and later begin with “NKA4” or “NKU4”. Continue reading
On October 3, 2016, a mother claimed that the active ingredient in the anti-nausea drug Zofran’s caused her son to develop cleft palate and cleft lip in the womb. The woman, from Oneida, New York, filed her case in the U.S. District Court of Massachusetts, where more than 280 additional Zofran lawsuits are currently consolidated.
In 2012, researchers at Harvard and Boston University discovered that women prescribed Zofran for nausea during pregnancy were more than twice as likely to deliver children with a cleft palate. Zofran’s warning label, however, does not mention a potential increased risk for cleft palate. Continue reading